Bergstrom Donald A — SEC insider filings

SEC reporting owner CIK 1709772. 67 insider filings on record with FilingPulse; latest filed 2026-11-20.

Transaction summary — filings shown

Covers the 50 most recent of 67 filings on record, filed 2022-05-02 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Relay Therapeutics, Inc. (RLAY)President, R&D47—51 legs · 466,357 sh · $6,199,65830
Fusion Pharmaceuticals Inc. (FUSN)Director3——6

Insider filings — Bergstrom Donald A

FiledFormIssuerReported transactionsSource
2026-11-204Relay Therapeutics, Inc. (RLAY)Sale (S): 10,269 @ $16.51EDGAR
2026-10-304Relay Therapeutics, Inc. (RLAY)Sale (S): 2,252 @ $18.62EDGAR
2026-09-094Relay Therapeutics, Inc. (RLAY)Sale (S): 8,530 @ $18.97EDGAR
2026-07-304Relay Therapeutics, Inc. (RLAY)Sale (S): 2,237 @ $18.61EDGAR
2026-07-084Relay Therapeutics, Inc. (RLAY)Sale (S): 8,660 @ $18.71EDGAR
2026-06-244Relay Therapeutics, Inc. (RLAY)Option exercise (M): 93,456 @ $4.12 · Sale (S): 93,456 @ $16.94 · Option exercise (M): 93,456 (derivative) @ $0EDGAR
2026-04-304Relay Therapeutics, Inc. (RLAY)Sale (S): 1,490 @ $14.79EDGAR
2026-01-294Relay Therapeutics, Inc. (RLAY)Sale (S): 18,895 @ $7.62 · Sale (S): 2,686 @ $8.45EDGAR
2026-01-154Relay Therapeutics, Inc. (RLAY)Grant/award (A): 575,000 (derivative) @ $0EDGAR
2025-10-304Relay Therapeutics, Inc. (RLAY)Sale (S): 30,897 @ $7.29EDGAR
2025-07-304Relay Therapeutics, Inc. (RLAY)Sale (S): 4,069 @ $3.74 · Sale (S): 26,701 @ $3.68EDGAR
2025-04-304Relay Therapeutics, Inc. (RLAY)Sale (S): 4,090 @ $3.17 · Sale (S): 27,472 @ $3EDGAR
2025-03-314Relay Therapeutics, Inc. (RLAY)Sale (S): 986 @ $2.84EDGAR
2025-01-304Relay Therapeutics, Inc. (RLAY)Sale (S): 3,220 @ $4.63 · Grant/award (A): 176,400 @ $0 · Sale (S): 46,407 @ $4.55 · Sale (S): 30,823 @ $4.42EDGAR
2025-01-144Relay Therapeutics, Inc. (RLAY)Grant/award (A): 400,000 (derivative) @ $0EDGAR
2024-12-314Relay Therapeutics, Inc. (RLAY)Sale (S): 657 @ $4.38EDGAR
2024-10-304Relay Therapeutics, Inc. (RLAY)Sale (S): 2,688 @ $6.06EDGAR
2024-10-014Relay Therapeutics, Inc. (RLAY)Sale (S): 648 @ $7.51EDGAR
2024-07-314Relay Therapeutics, Inc. (RLAY)Sale (S): 2,698 @ $8.85EDGAR
2024-07-014Relay Therapeutics, Inc. (RLAY)Sale (S): 648 @ $6.26EDGAR
2024-06-044Fusion Pharmaceuticals Inc. (FUSN)Disposition to issuer (D): 34,000 (derivative) · Disposition to issuer (D): 17,000 (derivative) · Disposition to issuer (D): 17,000 (derivative) · Disposition to issuer (D): 17,000 (derivative)EDGAR
2024-04-294Relay Therapeutics, Inc. (RLAY)Sale (S): 2,686 @ $6.38EDGAR
2024-03-294Relay Therapeutics, Inc. (RLAY)Sale (S): 765 @ $7.70EDGAR
2024-01-314Relay Therapeutics, Inc. (RLAY)Sale (S): 3,178 @ $9.64EDGAR
2024-01-184Relay Therapeutics, Inc. (RLAY)Grant/award (A): 300,000 @ $0EDGAR
2023-12-294Relay Therapeutics, Inc. (RLAY)Sale (S): 977 @ $11.51EDGAR
2023-11-014Relay Therapeutics, Inc. (RLAY)Sale (S): 3,451 @ $6.03EDGAR
2023-09-294Relay Therapeutics, Inc. (RLAY)Grant/award (A): 1,228 @ $10.68 · Sale (S): 648 @ $8.38EDGAR
2023-07-314Relay Therapeutics, Inc. (RLAY)Sale (S): 2,683 @ $11.80EDGAR
2023-06-284Relay Therapeutics, Inc. (RLAY)Sale (S): 647 @ $12.12EDGAR
2023-06-144Fusion Pharmaceuticals Inc. (FUSN)Grant/award (A): 17,000 (derivative) @ $0EDGAR
2023-06-014/ARelay Therapeutics, Inc. (RLAY)Sale (S): 2,850 @ $11.16EDGAR
2023-05-014Relay Therapeutics, Inc. (RLAY)Sale (S): 1,383 @ $11.16EDGAR
2023-03-284Relay Therapeutics, Inc. (RLAY)Sale (S): 763 @ $15.36EDGAR
2023-01-314Relay Therapeutics, Inc. (RLAY)Sale (S): 1,429 @ $21.56EDGAR
2023-01-194Relay Therapeutics, Inc. (RLAY)Grant/award (A): 160,390 @ $0 · Grant/award (A): 160,390 (derivative) @ $0 · Grant/award (A): 160,390 (derivative) @ $0EDGAR
2022-12-284Relay Therapeutics, Inc. (RLAY)Sale (S): 980 @ $14.49EDGAR
2022-11-014Relay Therapeutics, Inc. (RLAY)Sale (S): 1,817 @ $21.54 · Option exercise (M): 8,000 @ $4.12 · Sale (S): 8,000 @ $22.75 · Option exercise (M): 8,000 (derivative) @ $0EDGAR
2022-10-044Relay Therapeutics, Inc. (RLAY)Option exercise (M): 8,000 @ $4.12 · Sale (S): 8,000 @ $22.43 · Option exercise (M): 8,000 (derivative) @ $0EDGAR
2022-09-294Relay Therapeutics, Inc. (RLAY)Sale (S): 976 @ $22.73EDGAR
2022-09-084Relay Therapeutics, Inc. (RLAY)Option exercise (M): 25,000 @ $4.12 · Sale (S): 25,000 @ $30 · Option exercise (M): 25,000 (derivative) @ $0EDGAR
2022-09-024Relay Therapeutics, Inc. (RLAY)Option exercise (M): 4,900 @ $4.12 · Sale (S): 4,900 @ $25.46 · Option exercise (M): 4,900 (derivative) @ $0EDGAR
2022-09-014Relay Therapeutics, Inc. (RLAY)Option exercise (M): 8,100 @ $4.12 · Sale (S): 8,100 @ $23.07 · Option exercise (M): 8,100 (derivative) @ $0EDGAR
2022-08-254Relay Therapeutics, Inc. (RLAY)Option exercise (M): 15,000 @ $4.12 · Sale (S): 15,000 @ $25 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2022-08-084Relay Therapeutics, Inc. (RLAY)Option exercise (M): 8,000 @ $4.12 · Sale (S): 8,000 @ $20 · Option exercise (M): 8,000 (derivative) @ $0EDGAR
2022-07-294Relay Therapeutics, Inc. (RLAY)Sale (S): 1,835 @ $21.27EDGAR
2022-07-084Relay Therapeutics, Inc. (RLAY)Option exercise (M): 8,000 @ $4.12 · Sale (S): 8,000 @ $20 · Option exercise (M): 8,000 (derivative) @ $0EDGAR
2022-06-284Relay Therapeutics, Inc. (RLAY)Option exercise (M): 8,000 @ $4.12 · Sale (S): 8,000 @ $20 · Sale (S): 999 @ $20.31 · Option exercise (M): 8,000 (derivative) @ $0EDGAR
2022-06-224Fusion Pharmaceuticals Inc. (FUSN)Grant/award (A): 17,000 (derivative) @ $0EDGAR
2022-05-024Relay Therapeutics, Inc. (RLAY)Sale (S): 1,811 @ $25.57 · Option exercise (M): 13,000 @ $4.12 · Sale (S): 13,000 @ $24.62 · Option exercise (M): 13,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1709772 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs